Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Association of Genetic Variations and Weight Loss Response to Naltrexone/Bupropion
NCT05919797Phase 4Recruiting
- Sponsor
- Columbia University
- Start
- Jun 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone + bupropion in obesity, sponsored by Columbia University. Started Jun 2023; status: recruiting.
02
Drugs
naltrexone + bupropion
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05919797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05919797.